Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

7 ways cath labs can work through the contrast media shortage without delays

When the ongoing contrast media shortage first started impacting health systems, one group in Ohio pledged not to delay a single procedure in its cath labs.

Targeted radionuclide alpha therapy study wins SNMMI's Abstract of the Year

The study touts the benefits of targeted radionuclide alpha therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who have not had success with other treatments.

High-intensity focused ultrasound effectively treats PCA, reduces side effects

Men with prostate cancer can avoid many of the unpleasant side effects of chemo, surgery and radiation therapy when they are treated with high-intensity focused ultrasound instead.

U.S. News & World Report children’s hospitals cardiology heart surgery

The top 10 children’s hospitals for cardiology and heart surgery

The 2022-2023 rankings include some familiar names at the top. Did your facility make the cut? 

COPD patients benefit from TAVR—but there are some significant risks to consider

When discussing the possibility of TAVR for a patient with COPD, it is crucial to consider the severity of their symptoms.  

PSMA PET mapping improves radiation therapy contouring after PCA recurrence

Salvage radiation therapy guidelines for patients with prostate cancer recurrence need to be updated to include findings identified on PSMA PET, according to new research shared at SNMMI’s annual conference this week. 

Multimodality imaging turns up serial thromboses following AstraZeneca COVID vaccination

Whole-body imaging reveals clinically undetectable blood clots in patients after their first dose of AstraZeneca's COVID vaccine.

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Corvia Medical raises $54M to continue studying implantable heart failure treatment

The company will use the funds to follow up on what it learned from the REDUCE LAP-HF II clinical trial.